SecBot SecBot

To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program.

H.R. 4881 Rep. Nicole Malliotakis (R-NY-11) In committee
Bill text PDF
  1. Introduced Jul 25
  2. Committee Jul 25
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jul 25, 2023Next: House vote
680d ago Dec 17, 2024: Referred to the Subcommittee on Health.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
2companies, 3 filings
Subscribe to see spend
Member trades
8trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

2 companies
Companies by sector
Biotech & Pharma 1Financials 1
Search all 2 companies, their asks and price moves Subscribe

Summary

This bill limits cost-sharing for covered drugs under the Medicare prescription drug benefit and Medicare Advantage.

Full summary2 paragraphs

Specifically, for costs above the deductible but below the annual out-of-pocket threshold, the bill limits cost-sharing to the average net price of the drug (i.e., the average amount paid less any rebates) or the cash price (i.e., the price charged to an individual without insurance), whichever is lower.

The Government Accountability Office must report on the bill's implementation.

Library of Congress summary, Jul 25, 2023

Summary versions
  • Introduced in HouseJul 25, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.